Team:LMU-Munich/Application/Expertise

From 2014.igem.org

(Difference between revisions)

Revision as of 14:07, 8 October 2014

TOUR

Experts

Medizin Innovativ - MedTech Pharma 2014

"Funktion": Congress and Exhibition

"Anliegen": Learn about new developments of the health sector and network with its experts

"What we learned": We gained an in depth-look into innovations of the broad medical field and their corresponding affairs and had a great opportunity to connect with participants and exhibitors from various disciplines.

To obtain an insight into the broad medical field, we participated at the two-day congress Medizin Innovativ taking place at the Nuremberg Convention Center in July. This congress with nearly 1000 participants has become one of the most important meeting points for the health sector in recent years. Combining a series of lectures on scientific-technical and operational market-related topics with a large exhibition with over 120 exhibitors, the congress provides ideal conditions to connect participants from various disciplines. The variety of participants from company representatives to scientists and clinical users has always been a unique feature. On the first day, we attended the lecture session about Regulatory Affairs: Pharma&Diagnostics'’ which helped us to get informed about the new European regulations on clinical trails and in which we learned about risk management of medical products. Later on, we heard about innovative Smart Medical Systems’'. During the breaks, we introduced our project idea to several exhibitors, such as representatives of pharmaceutical companies or patent lawyers, in order to receive feedback, first estimations about its feasibility and problems we might face. The next day, we continued our tour through the exhibition and talked to authorities and companies focusing on the design and accomplishment of clinical trails. Moreover, we had a look at the poster session, where scientists from universities and research institutions revealed their latest results. In the afternoon, we participated in the lecture session about Market Access Strategies, where we heard about different financing strategies and price regulations on the European market. All in all, the congress was a great opportunity to get introduced into all facets of the medical field. We had an awesome chance to network with experts and are very thankful for their kind cooperativeness and their feedback, which gave us a lot input for our further considerations on our project’s potential and its implementation strategy.

Find more impressions and information:

http://www.medtech-pharma.de/english/congress/congress.aspx

Hi there!

Welcome to our Wiki! I'm BaKillus, the pathogen-hunting microbe, and I'll guide you on this tour through our project. If you want to learn more about a specific step, you can simply close the tour and come back to it anytime you like. So let's start!

What's the problem?

First of all, what am I doing here? The problem is, pathogenic bacteria all around the world are becoming more and more resistant against antimicrobial drugs. One major reason for the trend is the inappropriate use of drugs. With my BaKillus super powers, I want to reduce this misuse and thus do my part to save global health.

Sensing of pathogens

To combat the pathogenic bacteria, I simply eavesdrop on their communication. Bacteria talk with each other via quorum sensing systems, which I use to detect them and trigger my responses.

Adhesion

The more specific and effective I can use my powers, the lower the danger is of provoking new resistance development. So I catch pathogens whenever I get hold of them and stick to them until my work is done.

Killing

Talking about my work - killing pathogens is finally what I am made for. In response to quorum sensing molecules of the pathogens, I export a range of antimicrobial substances leading to dissipation of biofilms and the killing of the targeted bacteria.

Suicide switch

When the job is done and all the bad guys are finished, you don't need a super hero anymore. So after fulfilling my work I say goodbye to the world by activating my suicide switch.

Application

Of course I'm not only a fictional hero, but a very real one. In two different prototypes, I could be used for diagnosis or treatment of pathogen-caused diseases. However, there is still a whole lot of regulational and economical questions that have to be answered before.

See you!

So now you know my short story - and it is time for me to return to my fight for a safer world. Feel free to take a closer look on my super powers, the process of my development or the plans for a medical application.

@@ Line 5: / Line 5: @@
 === Medizin Innovativ - MedTech Pharma 2014 ===
 "Funktion":  Congress and Exhibition
 "Anliegen": Learn about new developments of the health sector and network with its experts
 "What we learned": We gained an in depth-look into innovations of the broad medical field and their corresponding affairs and  had a great opportunity to connect with participants and exhibitors from various disciplines.
-To obtain an insight into the broad medical field, we participated at the two-day congress ""Medizin Innovativ"" taking place at the Nuremberg Convention Center in July. This congress with nearly 1000 participants has become one of the most important meeting points for the health sector in recent years. Combining a series of lectures on scientific-technical and operational market-related topics with a large exhibition with over 120 exhibitors, the congress provides ideal conditions to connect participants from various disciplines. The variety of participants from company representatives to scientists and clinical users has always been a unique feature.
+To obtain an insight into the broad medical field, we participated at the two-day congress ''Medizin Innovativ'' taking place at the Nuremberg Convention Center in July. This congress with nearly 1000 participants has become one of the most important meeting points for the health sector in recent years. Combining a series of lectures on scientific-technical and operational market-related topics with a large exhibition with over 120 exhibitors, the congress provides ideal conditions to connect participants from various disciplines. The variety of participants from company representatives to scientists and clinical users has always been a unique feature.
-On the first day, we attended the lecture session about 'Regulatory Affairs: Pharma&Diagnostics’ which helped us to get informed about the new European regulations on clinical trails and in which we learned about risk management of medical products. Later on, we heard about innovative 'Smart Medical Systems’. During the breaks, we introduced our project idea to several exhibitors, such as representatives of pharmaceutical companies or patent lawyers, in order to receive feedback, first estimations about its feasibility and problems we might face. The next day, we continued our tour through the exhibition and talked to authorities and companies focusing on the design and accomplishment of clinical trails. Moreover, we had a look at the poster session, where scientists from universities and research institutions revealed their latest results. In the afternoon, we participated in the lecture session about 'Market Access Strategies', where we heard about different financing strategies and price regulations on the European market.
+On the first day, we attended the lecture session about ''Regulatory Affairs: Pharma&Diagnostics'’ which helped us to get informed about the new European regulations on clinical trails and in which we learned about risk management of medical products. Later on, we heard about innovative ''Smart Medical Systems’'. During the breaks, we introduced our project idea to several exhibitors, such as representatives of pharmaceutical companies or patent lawyers, in order to receive feedback, first estimations about its feasibility and problems we might face. The next day, we continued our tour through the exhibition and talked to authorities and companies focusing on the design and accomplishment of clinical trails. Moreover, we had a look at the poster session, where scientists from universities and research institutions revealed their latest results. In the afternoon, we participated in the lecture session about ''Market Access Strategies'', where we heard about different financing strategies and price regulations on the European market.
 All in all, the congress was a great opportunity to get introduced into all facets of the medical field. We had an awesome chance to network with experts and are very thankful for their kind cooperativeness and their feedback, which gave us a lot input for our further considerations on our project’s potential and its implementation strategy.
+Find more impressions and information:
+http://www.medtech-pharma.de/english/congress/congress.aspx
 {{Template:Team:LMU-Munich/Playground/footer}}
 <html><script>initiateNavigation("application");</script></html>